Klaartje Somers

9PUBLICATIONS
68CO-AUTHORS
Haematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
NAD Metabolism in Acute Myeloid Leukaemia: Biological Rationale and Therapeutic Opportunities.

|Jun 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Feb 21, 2025
The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma.

Mujahid Azfar, Weiman Gao, Chris Van den Haute

|Feb 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemia.

Mawar Karsa, Lin Xiao, Emma Ronca

|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.

Ernest Moles, Christopher B Howard, Pie Huda

|May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.

Lin Xiao, Klaartje Somers, Jayne Murray

Pageof 2

Frequent Collaborators

5 joint publications

Michelle Haber

4 joint publications

Murray D Norris

3 joint publications

Chelsea Mayoh

3 joint publications

Jamie I Fletcher